APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rotavirus Infections Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rotavirus Infections Drug Industry Growth and Trends Forecast to 2032

22 December 202597 pages

Choose your research edition.

Industry ResearchRotavirus Infections Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Rotavirus Infections Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Rotavirus Infections Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rotavirus Infections Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Rotavirus Infections Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rotavirus Infections Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rotavirus Infections Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rotavirus Infections Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rotavirus Infections Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rotavirus Infections Drug include Wuhan Institute of Biological Products Co Ltd, Beijing Minhai Biotechnology Co Ltd, UMN Pharma Inc, Serum Institute of India Ltd, Nanotherapeutics Inc, Medicago Inc, Curevac AG, Biological E Ltd and Bharat Biotech International Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rotavirus Infections Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rotavirus Infections Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rotavirus Infections Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rotavirus Infections Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rotavirus Infections Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rotavirus Infections Drug Market by Company

Wuhan Institute of Biological Products Co Ltd

Beijing Minhai Biotechnology Co Ltd

UMN Pharma Inc

Serum Institute of India Ltd

Nanotherapeutics Inc

Medicago Inc

Curevac AG

Biological E Ltd

Bharat Biotech International Ltd

Rotavirus Infections Drug Segment by Type

UMN-2001

RV-625

RV-3BB

Rotavac-5C

Others

Rotavirus Infections Drug Segment by Application

Clinic

Hospital

Others

Rotavirus Infections Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rotavirus Infections Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rotavirus Infections Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rotavirus Infections Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rotavirus Infections Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rotavirus Infections Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of UMN-2001 Table 2. Major Company of RV-625 Table 3. Major Company of RV-3BB Table 4. Major Company of Rotavac-5C Table 5. Major Company of Others Table 6. Global Rotavirus Infections Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 8. Global Rotavirus Infections Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Rotavirus Infections Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Rotavirus Infections Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 13. Global Rotavirus Infections Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Rotavirus Infections Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Rotavirus Infections Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Rotavirus Infections Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 18. North America Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Rotavirus Infections Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Rotavirus Infections Drug Industry Trends Table 28. Rotavirus Infections Drug Industry Drivers Table 29. Rotavirus Infections Drug Industry Opportunities and Challenges Table 30. Rotavirus Infections Drug Industry Restraints Table 31. Global Rotavirus Infections Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Rotavirus Infections Drug Revenue Market Share by Company (2021-2026) Table 33. Global Rotavirus Infections Drug Sales by Company (2021-2026) & (k units) Table 34. Global Rotavirus Infections Drug Sales Share by Company (2021-2026) Table 35. Global Rotavirus Infections Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Rotavirus Infections Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Rotavirus Infections Drug Major Company Production Sites and Headquarters Table 38. Global Rotavirus Infections Drug Company, Product Type & Application Table 39. Global Rotavirus Infections Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Rotavirus Infections Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Rotavirus Infections Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Rotavirus Infections Drug Sales by Region (2021-2026) & (k units) Table 44. Global Rotavirus Infections Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Rotavirus Infections Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Rotavirus Infections Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Rotavirus Infections Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Rotavirus Infections Drug Sales by Region (2027-2032) & (k units) Table 49. Global Rotavirus Infections Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Rotavirus Infections Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Rotavirus Infections Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Rotavirus Infections Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Rotavirus Infections Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 55. Global Rotavirus Infections Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Rotavirus Infections Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Rotavirus Infections Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 60. Global Rotavirus Infections Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Rotavirus Infections Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Rotavirus Infections Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Rotavirus Infections Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 65. North America Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Rotavirus Infections Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Wuhan Institute of Biological Products Co Ltd Company Information Table 75. Wuhan Institute of Biological Products Co Ltd Business Overview Table 76. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio Table 78. Wuhan Institute of Biological Products Co Ltd Recent Development Table 79. Beijing Minhai Biotechnology Co Ltd Company Information Table 80. Beijing Minhai Biotechnology Co Ltd Business Overview Table 81. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio Table 83. Beijing Minhai Biotechnology Co Ltd Recent Development Table 84. UMN Pharma Inc Company Information Table 85. UMN Pharma Inc Business Overview Table 86. UMN Pharma Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. UMN Pharma Inc Rotavirus Infections Drug Product Portfolio Table 88. UMN Pharma Inc Recent Development Table 89. Serum Institute of India Ltd Company Information Table 90. Serum Institute of India Ltd Business Overview Table 91. Serum Institute of India Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio Table 93. Serum Institute of India Ltd Recent Development Table 94. Nanotherapeutics Inc Company Information Table 95. Nanotherapeutics Inc Business Overview Table 96. Nanotherapeutics Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio Table 98. Nanotherapeutics Inc Recent Development Table 99. Medicago Inc Company Information Table 100. Medicago Inc Business Overview Table 101. Medicago Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Medicago Inc Rotavirus Infections Drug Product Portfolio Table 103. Medicago Inc Recent Development Table 104. Curevac AG Company Information Table 105. Curevac AG Business Overview Table 106. Curevac AG Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Curevac AG Rotavirus Infections Drug Product Portfolio Table 108. Curevac AG Recent Development Table 109. Biological E Ltd Company Information Table 110. Biological E Ltd Business Overview Table 111. Biological E Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Biological E Ltd Rotavirus Infections Drug Product Portfolio Table 113. Biological E Ltd Recent Development Table 114. Bharat Biotech International Ltd Company Information Table 115. Bharat Biotech International Ltd Business Overview Table 116. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio Table 118. Bharat Biotech International Ltd Recent Development Table 119. North America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 121. North America Rotavirus Infections Drug Sales Market Share by Country (2021-2026) Table 122. North America Rotavirus Infections Drug Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Rotavirus Infections Drug Sales Market Share Forecast by Country (2027-2032) Table 124. North America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Rotavirus Infections Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Rotavirus Infections Drug Market Share by Country (2021-2026) Table 127. North America Rotavirus Infections Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Rotavirus Infections Drug Market Share Forecast by Country (2027-2032) Table 129. Europe Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 131. Europe Rotavirus Infections Drug Sales Market Share by Country (2021-2026) Table 132. Europe Rotavirus Infections Drug Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Rotavirus Infections Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Rotavirus Infections Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Rotavirus Infections Drug Market Share by Country (2021-2026) Table 137. Europe Rotavirus Infections Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Rotavirus Infections Drug Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Rotavirus Infections Drug Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Rotavirus Infections Drug Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Rotavirus Infections Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Rotavirus Infections Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Rotavirus Infections Drug Market Share by Country (2021-2026) Table 147. Asia-Pacific Rotavirus Infections Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Rotavirus Infections Drug Market Share Forecast by Country (2027-2032) Table 149. Latin America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 151. Latin America Rotavirus Infections Drug Sales Market Share by Country (2021-2026) Table 152. Latin America Rotavirus Infections Drug Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Rotavirus Infections Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Rotavirus Infections Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Rotavirus Infections Drug Market Share by Country (2021-2026) Table 157. Latin America Rotavirus Infections Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Rotavirus Infections Drug Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Rotavirus Infections Drug Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Rotavirus Infections Drug Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Rotavirus Infections Drug Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Rotavirus Infections Drug Market Share by Country (2021-2026) Table 167. Middle East and Africa Rotavirus Infections Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Rotavirus Infections Drug Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Rotavirus Infections Drug Distributors List Table 172. Rotavirus Infections Drug Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Rotavirus Infections Drug Image Figure 2. Global Rotavirus Infections Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rotavirus Infections Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Rotavirus Infections Drug Sales (2021-2032) & (k units) Figure 5. UMN-2001 Image Figure 6. Global UMN-2001 Sales YoY Growth (2021-2032) & (k units) Figure 7. RV-625 Image Figure 8. Global RV-625 Sales YoY Growth (2021-2032) & (k units) Figure 9. RV-3BB Image Figure 10. Global RV-3BB Sales YoY Growth (2021-2032) & (k units) Figure 11. Rotavac-5C Image Figure 12. Global Rotavac-5C Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Rotavirus Infections Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Rotavirus Infections Drug Market Share by Type 2025 VS 2032 Figure 17. North America Rotavirus Infections Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Rotavirus Infections Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Rotavirus Infections Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Rotavirus Infections Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Rotavirus Infections Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Rotavirus Infections Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Rotavirus Infections Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Rotavirus Infections Drug Market Share by Application 2025 VS 2032 Figure 37. North America Rotavirus Infections Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Rotavirus Infections Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Rotavirus Infections Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Rotavirus Infections Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Rotavirus Infections Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Rotavirus Infections Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Rotavirus Infections Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Rotavirus Infections Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Rotavirus Infections Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Rotavirus Infections Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Rotavirus Infections Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Rotavirus Infections Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Rotavirus Infections Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Rotavirus Infections Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Rotavirus Infections Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Rotavirus Infections Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Rotavirus Infections Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Rotavirus Infections Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Rotavirus Infections Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Rotavirus Infections Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Rotavirus Infections Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Rotavirus Infections Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Rotavirus Infections Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Rotavirus Infections Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Rotavirus Infections Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Rotavirus Infections Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Rotavirus Infections Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Rotavirus Infections Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Rotavirus Infections Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Rotavirus Infections Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • UMN-2001
  • RV-625
  • RV-3BB
  • Rotavac-5C
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Wuhan Institute of Biological Products Co Ltd
  • Beijing Minhai Biotechnology Co Ltd
  • UMN Pharma Inc
  • Serum Institute of India Ltd
  • Nanotherapeutics Inc
  • Medicago Inc
  • Curevac AG
  • Biological E Ltd
  • Bharat Biotech International Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rotavirus Infections Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rotavirus Infections Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rotavirus Infections Drug Market by Type
  6. 1.3.1 UMN-2001
  7. 1.3.2 RV-625
  8. 1.3.3 RV-3BB
  9. 1.3.4 Rotavac-5C
  10. 1.3.5 Others
  11. 1.4 Global Rotavirus Infections Drug Market Size by Type
  12. 1.4.1 Global Rotavirus Infections Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Rotavirus Infections Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Rotavirus Infections Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Rotavirus Infections Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Rotavirus Infections Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Rotavirus Infections Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Rotavirus Infections Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Rotavirus Infections Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rotavirus Infections Drug Industry Trends
  2. 2.2 Rotavirus Infections Drug Industry Drivers
  3. 2.3 Rotavirus Infections Drug Industry Opportunities and Challenges
  4. 2.4 Rotavirus Infections Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rotavirus Infections Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Rotavirus Infections Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Rotavirus Infections Drug Price (2021-2026)
  4. 3.4 Global Rotavirus Infections Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rotavirus Infections Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Rotavirus Infections Drug Company, Product Type & Application
  7. 3.7 Global Rotavirus Infections Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rotavirus Infections Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rotavirus Infections Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rotavirus Infections Drug Tier 1, Tier 2, and Tier 3
4 Rotavirus Infections Drug Regional Status and Outlook
  1. 4.1 Global Rotavirus Infections Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rotavirus Infections Drug Historic Market Size by Region
  3. 4.2.1 Global Rotavirus Infections Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rotavirus Infections Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rotavirus Infections Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rotavirus Infections Drug Forecasted Market Size by Region
  7. 4.3.1 Global Rotavirus Infections Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rotavirus Infections Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rotavirus Infections Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rotavirus Infections Drug by Application
  1. 5.1 Rotavirus Infections Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Rotavirus Infections Drug Market Size by Application
  6. 5.2.1 Global Rotavirus Infections Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rotavirus Infections Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rotavirus Infections Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rotavirus Infections Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rotavirus Infections Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rotavirus Infections Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rotavirus Infections Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rotavirus Infections Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Institute of Biological Products Co Ltd
  2. 6.1.1 Wuhan Institute of Biological Products Co Ltd Company Information
  3. 6.1.2 Wuhan Institute of Biological Products Co Ltd Business Overview
  4. 6.1.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio
  6. 6.1.5 Wuhan Institute of Biological Products Co Ltd Recent Developments
  7. 6.2 Beijing Minhai Biotechnology Co Ltd
  8. 6.2.1 Beijing Minhai Biotechnology Co Ltd Company Information
  9. 6.2.2 Beijing Minhai Biotechnology Co Ltd Business Overview
  10. 6.2.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio
  12. 6.2.5 Beijing Minhai Biotechnology Co Ltd Recent Developments
  13. 6.3 UMN Pharma Inc
  14. 6.3.1 UMN Pharma Inc Company Information
  15. 6.3.2 UMN Pharma Inc Business Overview
  16. 6.3.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 UMN Pharma Inc Rotavirus Infections Drug Product Portfolio
  18. 6.3.5 UMN Pharma Inc Recent Developments
  19. 6.4 Serum Institute of India Ltd
  20. 6.4.1 Serum Institute of India Ltd Company Information
  21. 6.4.2 Serum Institute of India Ltd Business Overview
  22. 6.4.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio
  24. 6.4.5 Serum Institute of India Ltd Recent Developments
  25. 6.5 Nanotherapeutics Inc
  26. 6.5.1 Nanotherapeutics Inc Company Information
  27. 6.5.2 Nanotherapeutics Inc Business Overview
  28. 6.5.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio
  30. 6.5.5 Nanotherapeutics Inc Recent Developments
  31. 6.6 Medicago Inc
  32. 6.6.1 Medicago Inc Company Information
  33. 6.6.2 Medicago Inc Business Overview
  34. 6.6.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Medicago Inc Rotavirus Infections Drug Product Portfolio
  36. 6.6.5 Medicago Inc Recent Developments
  37. 6.7 Curevac AG
  38. 6.7.1 Curevac AG Company Information
  39. 6.7.2 Curevac AG Business Overview
  40. 6.7.3 Curevac AG Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Curevac AG Rotavirus Infections Drug Product Portfolio
  42. 6.7.5 Curevac AG Recent Developments
  43. 6.8 Biological E Ltd
  44. 6.8.1 Biological E Ltd Company Information
  45. 6.8.2 Biological E Ltd Business Overview
  46. 6.8.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biological E Ltd Rotavirus Infections Drug Product Portfolio
  48. 6.8.5 Biological E Ltd Recent Developments
  49. 6.9 Bharat Biotech International Ltd
  50. 6.9.1 Bharat Biotech International Ltd Company Information
  51. 6.9.2 Bharat Biotech International Ltd Business Overview
  52. 6.9.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio
  54. 6.9.5 Bharat Biotech International Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Rotavirus Infections Drug Sales by Country
  2. 7.1.1 North America Rotavirus Infections Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rotavirus Infections Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Rotavirus Infections Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rotavirus Infections Drug Market Size by Country
  6. 7.2.1 North America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rotavirus Infections Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Rotavirus Infections Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rotavirus Infections Drug Sales by Country
  2. 8.1.1 Europe Rotavirus Infections Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rotavirus Infections Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Rotavirus Infections Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rotavirus Infections Drug Market Size by Country
  6. 8.2.1 Europe Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rotavirus Infections Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rotavirus Infections Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rotavirus Infections Drug Sales by Country
  2. 9.1.1 Asia-Pacific Rotavirus Infections Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rotavirus Infections Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rotavirus Infections Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rotavirus Infections Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rotavirus Infections Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rotavirus Infections Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rotavirus Infections Drug Sales by Country
  2. 10.1.1 South America Rotavirus Infections Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rotavirus Infections Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Rotavirus Infections Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rotavirus Infections Drug Market Size by Country
  6. 10.2.1 South America Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rotavirus Infections Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Rotavirus Infections Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rotavirus Infections Drug Sales by Country
  2. 11.1.1 Middle East and Africa Rotavirus Infections Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rotavirus Infections Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rotavirus Infections Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rotavirus Infections Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Rotavirus Infections Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rotavirus Infections Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rotavirus Infections Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rotavirus Infections Drug Value Chain Analysis
  2. 12.1.1 Rotavirus Infections Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rotavirus Infections Drug Production Mode & Process
  7. 12.2 Rotavirus Infections Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rotavirus Infections Drug Distributors
  10. 12.2.3 Rotavirus Infections Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst